As previously mentioned, the simultaneous antagonism of the 5-HT3R and stimulation of the α7 nAChR, along with activation of the 5-HT4R, or activation/antagonism of the 5-HT6R can enhance ACh release and mitigate cognitive deficits in rodents. The gene discussed is HTR3A; the disease is Cognitive impairment.